5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model (Q34243207)

31 July 2017

title

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model (English)

1 reference

31 July 2017

1 reference

G. A. Kennett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1352056

17 September 2022

publication date

1 January 1992

1 reference

31 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1352056

17 September 2022

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

31 July 2017

volume

107

1 reference

31 July 2017

issue

2-3

1 reference

31 July 2017

page(s)

379-384

1 reference

Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Zacopride: anxiolytic profile in rodent and primate models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Mianserin and doxepin in the treatment of outpatient depression with anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245165

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

21 January 2018

1 reference

12 December 2020

Tryptamine antagonists and punished behavior.

1 reference

12 December 2020

5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists

1 reference

12 December 2020

Comparative double-blind trial of mianserin hydrochloride (Organon GB94) and diazepam in patients with depressive illness

1 reference

12 December 2020

Serotonin and anxiety revisited

1 reference

12 December 2020

Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

1 reference

12 December 2020

Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants

1 reference

12 December 2020

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1 reference

12 December 2020

A Controlled Comparative Trial of Mianserin and Diazepam in the Treatment of Anxiety States in Psychiatric Out-Patients

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes

1 reference

12 December 2020

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1 reference

12 December 2020

Antidepressant drugs normalize the increased social behaviour of pairs of male rats induced by short term isolation

1 reference

12 December 2020

In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist

1 reference

12 December 2020

The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

1 reference

12 December 2020

Mianserin in the treatment of depressive illness and anxiety states in general practice

1 reference

12 December 2020

Recent developments in 5HT-related pharmacology of animal models of anxiety

1 reference

12 December 2020

LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat

1 reference

12 December 2020

Comparison of the effects of the benzodiazepine midazolam and three serotonin antagonists on a consummatory conflict paradigm

1 reference

12 December 2020

Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

1 reference

12 December 2020

Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors

1 reference

12 December 2020

An in vivo model for investigating alpha 1- and alpha 2-receptors in the CNS: studies with mianserin

1 reference

12 December 2020

Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine

1 reference

12 December 2020

Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex

1 reference

12 December 2020

(—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone

1 reference

12 December 2020

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites

1 reference

12 December 2020

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

12 December 2020

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

1 reference

12 December 2020

Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study

1 reference

12 December 2020

5-HT1B agonists induce anorexia at a postsynaptic site

1 reference

12 December 2020

[3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes

1 reference

12 December 2020

Mechanism of action of the benzodiazepines: behavioral aspect.

1 reference

12 December 2020

Role of 5-hydroxytryptamine in amphetamine effects on punished and unpunished behaviour

1 reference

12 December 2020

Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour

1 reference

12 December 2020

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

12 December 2020

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

1 reference

12 December 2020

Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin

1 reference

12 December 2020

Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release

1 reference

12 December 2020

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus

1 reference

12 December 2020

Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

1 reference

12 December 2020

Pharmacological characterisation of a modified social interaction model of anxiety in the rat.

1 reference

12 December 2020

Effect of metergoline on human anxiety

1 reference

12 December 2020

Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245165

1 reference

Dimensions publication ID

31 July 2017

1022574865

0 references

1 reference